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The cationic chloro complexes [(arene)Ru(H2NNH2)Cl]+ (1:
arene = C6H6; 2: arene = p-MeC6H4iPr; 3: arene = C6Me6)
have been synthesised from the corresponding arene ruthe-
nium dichloride dimers and enantiopure (R,R or S,S) trans-
1,2-diaminocyclohexane (H2NNH2) and isolated as the
chloride salts. The compounds are all water-soluble and, in
the case of the hexamethylbenzene derivative 3, the aqua
complex formed upon hydrolysis [(C6Me6)Ru(H2NNH2)-
OH2]2+ (4) could be isolated as the tetrafluoroborate salt. The
molecular structures of 3 and 4 have been determined by
single-crystal X-ray diffraction analyses of [(C6Me6)Ru-
(H2NNH2)Cl]Cl and [(C6Me6)Ru(H2NNH2)OH2][BF4]2.
Treatment of [Ru2(arene)2Cl4] with the monotosylated trans-
1,2-diaminocyclohexane derivative (TsHNNH2) does not
yield the expected cationic complexes, analogous to 1–3 but
Introduction
Water-soluble organometallic complexes continue to at-
tract growing interest for applications in catalysis because
of environmentally friendly processing, simple product sep-
aration and pH dependent selectivity in aqueous media.
The first arene ruthenium aqua complexes were observed
by NMR spectroscopy in 1972 when Zelonka and Baird
dissolved [(C6H6)Ru2Cl4] in D2O.[1] The osmium complex
[(C6H6)Os(H2O)3]2+ was synthesised in an analogous man-
ner and characterised spectroscopically by Hung et al.[2]
Stebler-Röthlisberger et al. finally succeeded in isolating the
first cationic benzene aqua complexes [(C6H6)Ru(H2O)3]2+
and [(C6H6)Os(H2O)3]2+ as the tosylate salts. The structure
of the triaqua(benzene)ruthenium() cation was confirmed
by a single-crystal X-ray structure analysis of the sulfate.[3]
Since these early reports, the chemistry of organometallic
aqua ions of the transition metals has steadily grown during
the 1980s and this topic was comprehensively reviewed by
Koelle.[4] Related reviews deal with water-soluble organo-
metallics complexed by hydrophilic ligands,[5] metal-medi-
ated organic synthesis in water[6] and catalysis by water-sol-
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the neutral deprotonated complexes [(arene)Ru(TsNNH2)-
Cl] (5: arene = C6H6; 6: arene = p-MeC6H4iPr; 7: arene =
C6Me6; 8: arene = C6H5COOMe). Hydrolysis of the chloro
complex 7 in aqueous solution gave, upon precipitation of
silver chloride, the corresponding monocationic aqua com-
plex [(C6Me6)Ru(TsHNNH2)(OH2)]+ (9) which was isolated
and characterised as its tetrafluoroborate salt. The enantio-
pure complexes 1–9 have been employed as catalysts for the
transfer hydrogenation of acetophenone in aqueous solution
using sodium formate and water as a hydrogen source. The
best results were obtained (60 °C) with 7, giving a catalytic
turnover frequency of 43 h–1 and an enantiomeric excess of
93%.
uble organometallic complexes in biphasic systems.[7] Re-
cently, Ogo reported the transfer hydrogenation of ketones
with HCO2Na as a hydrogen donor, catalysed by achiral
water-soluble Ru() complexes.[8] The intermediary formato
and hydrido complexes [(C6Me6)Ru(bipy)(OCHO)]+ and
[(C6Me6)Ru(bipy)H]+ could be isolated and structurally
characterised.[8,9] We have also described the synthesis and
catalytic activity of cationic arene ruthenium complexes
containing 1,10-phenanthroline and its derivatives as che-
lating N,N-donor ligands.[10]
Several recent reports deal with asymmetric transfer hy-
drogenation of ketones with formate in aqueous media
using active catalytic systems based on [(p-MeC6H4iPr)-
RuCl2]2 and N-(p-toluenesulfonyl)-1,2-diphenyl-ethylenedi-
amine and its derivatives[11–14] 2-(N-anilinocarboxy)-pyr-
rolidine[15] or aminoethanol attached to cyclodextrin.[16]
These catalytic systems show good activities and enantio-
selectivities but the catalysts are formed in situ from precur-
sors and are not isolated. 1,2-dephenylethylendiamine
(“Noyori’s ligand”)[17,18] and also trans-1,2-diaminocyclo-
hexane form, in combination with [(p-MeC6H4iPr)RuCl2]2,
an active catalytic system for the transfer hydrogenation of
ketones in 2-propanol or in an Et3N/HCOOH azeotropic
mixture.[19]
In this paper we report a series of water-soluble arene
ruthenium complexes containing enantiopure trans-1,2-di-
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aminocyclohexane and derivatives thereof as chelating N,N-
donor ligands. We also describe the catalytic activity of
these complexes in the transfer hydrogenation of aromatic
ketones to give the corresponding chiral secondary alcohol
with sodium formate as a hydrogen donor in aqueous solu-
tion.
Results and Discussion
Synthesis of Enantiopure Arene Ruthenium Complexes
Containing the trans-1,2-Diaminocyclohexane Ligand (1–4)
The monocationic chloro complexes [(arene)-
Ru(H2NNH2)Cl]+ (1–3) containing the N,N donor as a
chelating ligand are accessible by treatment of the dimeric
arene ruthenium complexes [(arene)RuCl2]2 with enantio-
pure (R,R or S,S) trans-1,2-diaminocyclohexane
(H2NNH2) at room temperature in dichloromethane solu-
tion [Equation (1)].
0.5 [(arene)RuCl2]2 + H2NNH2 
[(arene)Ru(H2NNH2)Cl]+ + Cl– (1)
The chloride salts of 1–3 are orange solids that dissolve
well in water, a property which can be used to remove unre-
acted materials. Since there is a risk of hydrolysis in water,
the aqueous solutions were filtered immediately and then
evaporated to dryness to give the analytically pure salts [1–
3]Cl. All compounds were obtained for both trans-1,2-di-
aminocyclohexane enantiomers (R,R or S,S) and were sub-
sequently characterised by 1H and 13C spectroscopy, mass
spectroscopy and elemental analysis. The molecular struc-
ture of 3 has been confirmed by a single-crystal X-ray struc-
ture analysis.
The chloro complex [(C6Me6)Ru(H2NNH2)Cl]+ (3) un-
dergoes hydrolysis in aqueous solution and gives, upon pre-
cipitation of silver chloride, the enantiopure dicationic aqua
complex [(C6Me6)Ru(H2NNH2)(OH2)]+ (4). Both
enantiomers (R,R or S,S) have been isolated as tetrafluo-
roborate salts and characterised by 1H and 13C spec-
troscopy, mass spectroscopy, elemental analysis and single-
crystal X-ray structure analysis.
Synthesis of Enantiopure Arene Ruthenium Complexes
Containing the N-Tosyl-trans-1,2-diaminocyclohexane
Ligand (5–9)
The reaction of [Ru2(arene)2Cl4] with the monotosylated
trans-1,2-diaminocyclohexane[20] (TsHNNH2) at room
temperature in dichloromethane solution does not give the
expected cationic complexes, analogous to 1–3, but the de-
protonated neutral complexes [(arene)Ru(TsNNH2)Cl]
(5–8) [Equation (2)].
0.5 [(arene)RuCl2]2 + TsHNNH2 
[(arene)Ru(TsNNH2)Cl] (2)
Similar to the known complex 6,[21] complexes 5, 7 and
8 are orange solids. The products obtained are quite soluble
in water but in order to avoid hydrolysis they were purified
by column chromatography on aluminium oxide using
methanol as eluent. All compounds were obtained for both
the N-Tosyl-trans-1,2-diaminocyclohexane enantiomers
(R,R or S,S) and were subsequently characterised by 1H
and 13C spectroscopy, mass spectroscopy and elemental
analysis.
The chloro complex [(C6Me6)Ru(TsNNH2)Cl] (7) un-
dergoes hydrolysis in aqueous solution and gives, upon pre-
cipitation of silver chloride, the enantiopure monocationic
aqua complex [(C6Me6)Ru(TsNNH2)(OH2)]+ (9). Both
enantiomers (R,R or S,S) were isolated as the tetrafluo-
roborate salts and characterised by 1H and 13C spec-
troscopy, mass spectroscopy and elemental analysis.
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Molecular Structures of [(C6Me6)Ru(R,R-H2NNH2)Cl]+
(R,R-3) and [(C6Me6)Ru(S,S-H2NNH2)(OH2)]2+ (S,S-4)
The compound [R,R-3][Cl]·2CHCl3 crystallises in the or-
thorhombic non-centrosymmetric space group P212121. The
molecular structure of [R,R-3][Cl]·2CHCl3 is depicted in
Figure 1. The structure of the cation consists of a pseudo-
tetrahedral arrangement of a ruthenium atom coordinated
to the η6-hexamethylbenzene ligand, the two nitrogen
atoms of the (R,R) trans-1,2-diaminocyclohexane ligand
and a chlorine atom. Ru–C distances fall within the range
2.183(2)–2.218(2) Å. As expected, the two amino groups of
the (R,R) trans-1,2-diaminocyclohexane ligand are in equa-
torial positions which is the more stable conformation.
Figure 1. Molecular structure of R,R-3; displacement ellipsoids are
shown at the 50% probability level; hydrogen atoms, the chloride
counter anion and chloroform molecule are omitted for clarity; se-
lected bond lengths [Å] and angles [°]: Ru(1)–N(1) 2.129(4), Ru(1)–
N(2) 2.130(4), Ru(1)–Cl(1) 2.4052(16); N(1)–Ru(1)–N(2) 79.26(16),
N(1)–Ru(1)–Cl(1) 83.06(15), N(2)–Ru(1)–Cl(1) 84.89(14).
The compound [S,S-4][BF4]2·H2O crystallises in the or-
thorhombic noncentrosymmetric space group P212121. The
molecular structure of [S,S-4][BF4]2·H2O is depicted in Fig-
ure 2. The structure of the cation consists of a pseudo-tetra-
hedral arrangement of a ruthenium atom coordinated to
the η6-hexamethylbenzene ligand, the two nitrogen atoms
of the (S,S) trans-1,2-diaminocyclohexane ligand and a
water molecule. Ru–C distances fall within the range
2.183(2)–2.218(2) Å. As expected, the two amino groups of
the (S,S) trans-1,2-diaminocyclohexane ligand are in equa-
torial positions which is the more stable conformation.
Figure 2. Molecular structure of S,S-4; displacement ellipsoids are
shown at the 50% probability level; hydrogen atoms, tetrafluoro-
borate counter anions and water molecule are omitted for clarity;
selected bond lengths [Å] and angles [°]: Ru(1)–N(1) 2.127(10),
Ru(1)–N(2) 2.125(11), Ru(1)–O(1) 2.188(7); N(1)–Ru(1)–N(2)
78.8(3), N(1)–Ru(1)–O(1) 81.9(4), N(2)–Ru(1)–O(1) 82.6(4).
Catalytic Application of 1–9 for the Transfer
Hydrogenation of Acetophenone and Derivatives with
Sodium Formate in Aqueous Solution
Based on the studies using a catalytic system composed
of the tosylated diphenylethanediamine (TsDPEN) with [(p-
MeC6H4iPr)RuCl2]2 for the asymmetric transfer hydrogena-
tion of ketones with sodium formate as hydrogen donor in
water,[11–14] we evaluated the catalytic potential of the trans-
diaminocyclohexane complexes 1–9 for this reaction using
acetophenone as a test substrate. The solubility of the cata-
lysts in water varies from 10 µmolmL–1 for the neutral com-
plexes 5–8 to 40 µmolmL–1 for the ionic compounds 1–4
and 9 at 60 °C.
All trans-diaminocyclohexane complexes 1–9 (both R,R
and S,S enantiomers) were found to catalyse the transfer
hydrogenation reaction of acetophenone to give phenyl-
ethanol in aqueous solution with sodium formate as a hy-
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drogen source (Table 1). However, the tosylated derivatives
5–7 and 9 shown higher activities and selectivities than the
non-tosylated complexes. The contribution of the donor ef-
fect of the substituents on the arene ligand is also obvious
as the enantiomeric excess (ee) increases from 54% for the
benzene complex 5 to 93% for the hexamethylbenzene com-
plex 7. This result is also consistent with the CH/π attrac-
tion model reported by Noyori.[22] The beneficial effect of
the donor substituents at the arene ligand was confirmed
by the use of complex 8 which gave a lower activity and
selectivity than those observed for the benzene complex 5.
Table 1. Catalytic enantioselective transfer hydrogenation of aceto-
phenone using the (1R,2R)-diaminocyclohexane ruthenium com-
plexes as catalysts and HCOONa as a hydrogen donor in water.[a]
Catalyst Conversion % (h)[b] ee %[b] TOF [h–1][c]
1 74 (16) 29 4.6
2 89 (16) 17 5.6
3 82 (16) 47 5.1
4 86 (16) 38 5.4
5 94 (2) 54 47
6 93 (2) 81 46.5
7 86 (2) 93 43
8 7 (2) 44 3.5
9 85 (2) 91 42.5
[a] Conditions: Reactions were carried out at 60 °C, pH = 9, in
5 mL of water and with acetophenone (1 mmol); the ratio catalyst/
substrate/formate was 1:100:500. [b] The conversion and the enan-
tiomeric excesses were determined by chiral HPLC analysis.
[c] TOF: turnover frequencies (mol of acetophenone converted to
phenylethanol per mol of catalyst per hour) were taken after 60%
conversion.
Figure 3. Postulated catalytic cycle for transfer hydrogenation catalysed by 9.
It may be assumed that the chloro complexes 1–3 and 5–
8 undergo hydrolysis to the corresponding aqua complexes
under catalytic conditions. Thus, the isolated aqua complex
9 shows the same activity and selectivity as the correspond-
ing chloro complex 7. We believe that the aqua complexes
react with the formate anion to give the corresponding for-
mato complexes as the catalytically active species. A pro-
posed catalytic cycle for derivative 9, based on the pioneer-
ing work of Noyori[17c] and Ogo[8] is shown in Figure 3.
The hypothesis of an η4 transition state (Figure 3) pos-
tulated by Ogo, in the case of the [(C6Me6)Ru(bipy)-
(OH2)]2+ complex[8] (bipy = 2,2’ bipyrimidine) is substanti-
ated by the arene substituent dependence of the catalytic
activity described above. Indeed, complex 7 containing do-
nor substituents on the arene ligand (arene = C6Me6, TOF
= 43 h–1), which would stabilise the transition species,
shows activity more than ten times greater than that of the
analogue 8 with an electron-withdrawing substituent at the
arene ligand (arene = C6H4CO2Me, TOF = 3.5 h–1).
The pH dependence of the catalytic activity[8,10] of 7 was
studied for the transfer hydrogenation of acetophenone to
give phenylethanol in aqueous solution. As Figure 4 reveals,
the best pH conditions were found to be around 9 which
corresponds to the pH obtained by addition of sodium for-
mate in water under catalytic conditions.
The temperature dependence of the catalytic activity of 7
was also studied for the same reaction. The curve obtained
(Figure 5) clearly shows that the catalytic conditions for the
activity of this reaction were found to be the best at 60 °C
without significant modification to the selectivity.
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Figure 4. pH-dependent profile of conversion () and enantiomeric
excess (ρ) for transfer hydrogenation of acetophenone (1 mmol)
using complex 7 as the catalyst and HCOONa as a hydrogen donor
in water (5 mL), at 60 °C, for 2 h, the catalyst/substrate/formate
ratio being 1:100:500.
Figure 5. Temperature-dependent profile of conversion () and en-
antiomeric excess (∆) for transfer hydrogenation of acetophenone
(1 mmol) using complex 7 as catalyst and HCOONa as hydrogen
donor in water (5 mL), at pH = 9, for 2 h, the catalyst/substrate/
formate ratio being 1:100:500.
The kinetic plot (Figure 6) shows that under these condi-
tions the reaction is almost complete after 3 h. The turnover
frequency calculated in this case, using the best catalyst pre-
cursor 7, is 43 h–1, comparable to those found for the
TsDPEN catalysts.[11–14]
Figure 6. Time dependence of conversion () and enantiomeric ex-
cess (∆) for transfer hydrogenation of acetophenone (1 mmol) using
complex 7 as catalyst and HCOONa as hydrogen donor in water
(5 mL), at 60 °C, pH = 9, the catalyst/substrate/formate ratio being
1:100:500.
The catalytic activity and selectivity of complex 7 have
also been determined for the transfer hydrogenation reac-
tion of para-substituted acetophenone under the same cata-
lytic conditions (Table 2).
Table 2. Enantioselective catalytic transfer hydrogenation of para-
substituted acetophenone using complex 7 as catalyst and
HCOONa as a hydrogen donor in water.[a]
Substituent Conversion % (h) ee % TOF [h–1][d]
CF3 70 (2)[c] 90[c] 35
NO2 57 (2)[c] 79[c] 28.5
Br 88 (2)[b] 90[b] 44
Me 84 (2)[b] 92[b] 42
OMe 65 (2)[c] 93[c] 32.5
[a] Conditions: reactions were carried out at 60 °C, at pH = 9, in
5 mL of water, acetophenone (1 mmol), the ratio catalyst/substrate/
formate being 1:100:500. [b] The conversion and the enantiomeric
excess were determined by chiral HPLC analysis. [c] The conversion
and the enantiomeric excess were determined by chiral GC analysis.
[d] TOF: turnover frequencies (mol of acetophenone converted to
phenylethanol per mol of catalyst per hour) were taken at 50%
conversion.
The catalytic system is rather tolerant with respect to the
substrate. There is no substantial limitation by electronic
effects of the substituents at the substrate molecule. Thus,
the enantioselectivity varies only slightly from 79% (para-
nitroacetophenone) to 93% (para-methoxyacetophenone)
with dramatically varying electronic densities in the aro-
matic rings of the substrates. The variation of the catalytic
activity from 28.5 h–1 (para-nitroacetophenone) to 44 h–1
(para-bromoacetophenone) is also not very pronounced.
Conclusions
In conclusion, we report here nine water-soluble chiral
arene ruthenium complexes containing trans-1,2-di-
aminocyclohexane or derivatives thereof as chelating li-
gands. All these complexes were found to catalyse the enan-
tioselective transfer hydrogenation of acetophenone to give
1-phenylethanol using sodium formate as a hydrogen source
in aqueous solution. The best results were obtained for 7 at
60 °C, giving a turnover frequency of 43 h–1 and an enantio-
meric excess of 93%. The corresponding aqua complex 9,
presumed to be the catalytic species, has been isolated and
characterised as its tetrafluoroborate salt.
Experimental Section
General: All manipulations were carried out in an inert atmosphere
using standard Schlenk techniques and freshly distilled solvents sat-
urated with nitrogen prior to use. The starting dimer [(arene)Ru-
Cl2]2[23,24] and the monotosylated diaminocyclohexane
(TsHNNH2)[20] were prepared according to the published meth-
ods. All other reagents were commercially available and were used
without further purification. NMR spectra were recorded on a
Bruker 400 MHz spectrometer using sodium 2,2-dimethyl-2-sila-
pentane-5-sulfonate in D2O as a 13C locking agent. Electrospray
mass spectra were obtained in the positive-ion mode with an LCQ
Finnigan mass spectrometer. Microanalyses were carried out by the
Laboratoire de Chimie Pharmaceutique, Université de Genève
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(Switzerland). All chemical characterisations given below were
found for both R,R and S,S enantiomers.
Preparation of the Enantiopure Chloro Complexes [(arene)-
Ru(H2NNH2)Cl]+ (arene = C6H6, p-MeC6H4iPr or C6Me6;
H2NNH2 = trans-1,2-diaminocyclohexane): Two equiv.
(0.30 mmol) of the appropriate enantiomer of trans-1,2-diaminocy-
clohexane (H2NNH2) were added to a suspension of [(arene)-
RuCl2]2 (0.15 mmol) in dichloromethane (30 mL). The mixture was
stirred for 4 h at room temperature, during this time the orange
colour became darker. After evaporation to dryness, the residue
was dissolved in water (20 mL). The solution was filtered, washed
with diethyl ether (2× 10 mL), and the aqueous solution was evapo-
rated to dryness giving the product in 75–85% yield.
[(C6H6)Ru(H2NNH2)Cl]Cl ([1]Cl): Yield 74%, 80.8 mg. 1H NMR
(400 MHz, D2O, 21 °C): δ = 1.03 (m, CH2), 1.18 (m, 3Jcis = 3.96,
3Jtrans = 11.36 Hz, CH), 1.57 (m, CH2), 1.83 (m, 3Jcis = 3.72, 3Jtrans
= 12.28 Hz, CH), 1.94 (m, CH2), 5.78 (s, C6H6) ppm. 13C NMR
(200 MHz, D2O, 21 °C): δ = 24.1 (CH2), 24.3 (CH2), 32.9 (CH2),
34.4 (CH2), 56.7 (CH), 61.0 (CH), 84.4 (C6H6) ppm. MS (ESI)
m/z = 329 [M]+. C12H20Cl2N2Ru (364.28): calcd. C 39.57, H 5.53,
N 7.69; found N 39.63, H 5.48, N 7.58.
[(p-MeC6H4Pri)Ru(H2NNH2)Cl]Cl ([2]Cl): Yield 85%, 107.1 mg.
1H NMR (400 MHz, D2O, 21 °C): δ = 1.07 (m, CH2), 1.21 (m,
CH), 1.28 (d, 3JH,H = 7 Hz, (CH3)2CH), 1.55 (m, CH2), 1.78 (m,
CH), 1.92 (m, CH2), 2.84 (m, 3JH,H = 7 Hz, CH(CH3)2), 5.61 (d,
3JH,H = 6 Hz, C6H4), 5.75 (d, 3JH,H = 6 Hz, C6H4) ppm. 13C NMR
(200 MHz, D2O, 21 °C): δ = 18.4 (CH3), 21.4 (CH(CH3)2), 24.1
(CH2), 24.3 (CH2), 31.0 (CH (CH3)2), 32.9 (CH2), 34.4 (CH2), 57.2
(CH), 61.1 (CH), 86.7 (C6H4), 103.9 (C6H4), 105.6 (C6H4) ppm.
MS (ESI): m/z = 385 [M+]. C16H28Cl2N2Ru (420.38): calcd. C
45.71, H 6.71, N 6.66; found N 45.58, H 6.69, N 6.58.
[(C6Me6)Ru(H2NNH2)Cl]Cl ([3]Cl): Yield 81%, 108.9 mg. 1H
NMR (400 MHz, D2O, 21 °C): δ = 1.11 (m, CH2), 1.21 (m, CH),
1.53 (m, CH2), 1.85 (m, CH), 1.98 (m, CH2), 2.08 (s, C6(CH3)
6) ppm. 13C NMR (200 MHz, D2O, 21 °C): δ = 15.2 (C6(CH3)6),
24.0 (CH2), 24.2 (CH2), 33.5 (CH2), 34.3 (CH2), 57.0 (CH), 60.9
(CH), 92.1 (C6(CH3)6) ppm. MS (ESI): m/z = 413 [M+].
C18H32N2Cl2Ru (448.44): calcd. C 48.21, H 7.19, N 6.25; found N
48.07, H 7.22, N 6.23.
Preparation of the Enantiopure Chloro [(arene)Ru(TsNNH2)Cl]
(arene = C6H6, p-MeC6H4iPr, C6Me6 or C6H4COOMe;
TsHNNH2 = N-tosyl-trans-1,2-diaminocyclohexane): Two equiv.
(0.30 mmol) of the appropriate enantiomer of N-tosyl-trans-1,2-di-
aminocyclohexane (TsHNNH2) were added to a suspension of
[(arene)RuCl2]2 (0.15 mmol) in dichloromethane (30 mL). The mix-
ture was stirred for 4 h at room temperature, during this time the
orange colour became darker. After evaporation to dryness the resi-
due was dissolved in a minimum of dichloromethane and then sub-
mitted to column chromatography on aluminium oxide using meth-
anol as eluent. The orange-yellow fraction was collected and the
solvent was evaporated to dryness giving the product in 70–75%
yield.
[(C6H6)Ru(TsNNH2)Cl] (5): Yield 70%, 93.9 mg. 1H NMR
(400 MHz, CDCl3, 21 °C): δ = 0.95 (m, CH2), 1.22 (m, 2 CH2),
1.43 (m, CH), 1.60 (m, CH2), 1.88 (m, CH), 2.28 (s, p-(CH3)
C6H4SO2), 5.78 (s, C6H6), 7.17 (d, J = 7.3 Hz, p-(CH3)C6H4SO2),
7.71 (d, J = 7.3 Hz, p-(CH3)C6H4SO2) ppm. 13C NMR (200 MHz,
CDCl3, 21 °C): δ = 21.5 (p-(CH3)C6H4SO2), 24.4 (CH2), 25.0
(CH2), 31.8 (CH2), 32.5 (CH2), 59.3 (CH), 60.0 (CH), 83.4 (C6H6),
127.2 (2 CH), 128.3 (2 CH), 137.9 (p-(CH3)C6H4SO2), 143.3 (p-
(CH3)C6H4SO2) ppm. MS (ESI): m/z = 447 [M – Cl]+.
C19H25ClN2O2RuS (482): calcd. C 47.34, H 5.23, N 5.81; found N
47.13, H 5.32, N 5.69.
[(p-MeC6H4iPr)Ru(TsNNH2)Cl] (6): Yield 73 %, 110.2 mg. 1H
NMR (400 MHz, CDCl3, 21 °C): δ = 1.05 (m, CH2), 1.25 (m, 2
CH2), 1.32 (d, 3JH,H = 7 Hz, (CH3)2CH), 1.53 (m, CH), 1.71 (m,
CH2), 1.99 (m, CH), 2.36 (s, p-(CH3)C6H4SO2), 2.86 (m, 3JH,H =
7 Hz, (CH3)2CH), 5.57 (d, 3JH,H = 6 Hz, C6H4), 5.77 (d, 3JH,H =
6 Hz, C6H4), 7.17 (d, 3JH,H = 8 Hz, p-(CH3)C6H4SO2), 7.71 (d,
3JH,H = 8 Hz, p-(CH3)C6H4SO2) ppm. 13C NMR (200 MHz,
CDCl3, 21 °C): δ = 18.4 (CH3), 21.4 (CH(CH3)2), 21.5 (p-(CH3)
C6H4SO2), 24.1 (CH2), 24.3 (CH2), 31.0 (CH(CH3)2), 33.5 (CH2),
34.2 (CH2), 57.2 (CH), 60.6 (CH), 86.8 (C6H4), 104.0 (C6H4), 105.5
(C6H4), 127.1 (p-(CH3)C6H4SO2), 128.3 (p-(CH3)C6H4SO2), 138.0
(p-(CH3)C6H4SO2), 142.7 (p-(CH3)C6H4SO2) ppm. MS (ESI): m/z
= 503 [M – Cl]+. C23H33ClN2O2RuS (538): calcd. C 51.34, H 6.18,
N 5.21; found N 51,28, H 6.06, N 5.16.
[(C6Me6)Ru(TsNNH2)Cl] (7): Yield 76 %, 121.1 mg. 1H NMR
(400 MHz, CDCl3, 21 °C): δ = 1.05 (m, CH2), 1.23 (m, CH), 1.33
(m, CH2), 1.44 (m, CH–CH2), 1.80 (m, CH), 2.09 (s, C6(CH3)6),
2.39 (s, p-(CH3)C6H4SO2), 7.28 (d, 3JH,H = 8 Hz, p-(CH3)
C6H4SO2), 7.77 (d, 3JH,H = 8 Hz, p-(CH3)C6H4SO2) ppm. 13C
NMR (200 MHz, CDCl3, 21 °C): δ = 15.1 (C6(CH3)6), 21.4 (p-
(CH3)C6H4SO2), 24.1 (CH2), 24.1 (CH2), 33.4 (CH2), 34.2 (CH2),
57.1 (CH), 61.1 (CH), 92.1 (C6(CH3)6), 127.1 (p-(CH3)C6H4SO2),
128.1 (p-(CH3)C6H4SO2), 137.8 (p-(CH3)C6H4SO2), 143.0 (p-(CH3)
C6H4SO2) ppm. MS (ESI): m/z = 531 [M – Cl]+.
C25H37ClN2O2RuS (566.16): calcd. C 53.04, H 6.59, N 4.95; found
N 52.96, H 6.48, N 5.12.
[(C6H4COOMe)Ru(TsNNH2)Cl] (8): Yield 71%, 110.8 mg. 1H
NMR (400 MHz, CDCl3, 25 °C): δ = 0.95 (m, CH2), 1.18 (m, CH2),
1.37 (m, CH), 1.65 (m, CH2), 1.92 (m, CH), 2.26 (s, p-(CH3)
C6H4SO2), 3.81 (s, C6H5COOCH3), 5.26 (dd, 3JH,H = 7.5, J = 8 Hz,
C6H5COOCH3), 5.86 (t, 3JH,H = 8 Hz, C6H5COOCH3), 6.32 (d,
3JH,H = 7.5 Hz, C6H5COOCH3), 7.21 (d, 3JH,H = 7.3 Hz, p-(CH3)
C6H4SO2), 7.68 (d, 3JH,H = 7.3 Hz, p-(CH3)C6H4SO2), ppm. 13C
NMR (200 MHz, CDCl3, 25 °C): δ = 21.5 (p-(CH3)C6H4SO2), 24.4
(CH2), 25.0 (CH2), 31.7 (CH2), 32.48 (CH2), 52.9 (C6H5COOCH3),
59.3 (CH), 60.01 (CH), 80.5 (C6H5COOCH3), 82.1
(C6H5COOCH3), 88.6 (C6H5COOCH3), 90.0 (C6H5COOCH3),
127.2 (2 CH), 128.3 (2 CH), 138.0 (p-(CH3)C6H4SO2), 142.8 (p-
(CH3)C6H4SO2), 165.4 (C6H5COOCH3) ppm. MS (ESI): m/z = 520
[M – Cl]+. C22H30ClN2O4RuS (555): calcd. C 47.60, H 5.45, N 5.05;
found N 47.48, H 5.28, N 4.96.
Preparation of the Enantiopure Aqua Complex [(C6Me6)-
Ru(H2NNH2)(OH2)]2+ (4) and [(C6Me6)Ru(TsNNH2)(OH2)]+
(9) (H2NNH2 = trans-1,2-diaminocyclohexane; TsHNNH2 = N-
tosyl-trans-1,2-diaminocyclohexane): To an aqueous solution of the
appropriate chloro complex, [(arene)Ru(H2NNH2)Cl]+ or [(ar-
ene)Ru(TsNNH2)Cl], was added one equiv. of silver sulfate
(0.30 mmol, 93.6 mg) in water (30 mL). After stirring for 1 h in the
dark at room temperature the white precipitate (AgCl) was re-
moved by filtration from the yellow solution. Solid NaBF4 was
added until saturation and a yellow precipitate appeared. The sus-
pension was then centrifuged, the solid dissolved in dry acetonitrile
(10 mL) and the resultant solution filtered through celite to elimin-
ate the excess NaBF4. After evaporation of the solvent, the tetra-
fluoroborate salt was obtained as a yellow-orange powder in quan-
titative yield.
[(C6Me6)Ru(H2NNH2)(OH2)](BF4)2 ([4](BF4)2): Yield 98 %,
167.6 mg. 1H NMR (400 MHz, D2O, 21 °C): δ = 1.09 (m, CH2),
1.22 (m, CH), 1.63 (m, CH2), 1.85 (m, CH), 1.89 (m, CH2), 2.12 (s,
C6(CH3)6). 13C NMR (200 MHz, D2O, 21 °C): δ = 15.2 (C6(CH3)6),
6
24.0 (CH2), 24.2 (CH2), 33.5 (CH2), 34.2 (CH2), 57.0 (CH), 60.9
(CH), 92.1 (C6(CH3)6). MS (ESI): m/z = 396 [M]+.
C18H34B2F8N2ORu (569.15): calcd. C 37.98, H 6.02, N 4.92; found
N 38.06, H 6.08, N 4.95.
[(C6Me6)Ru(TsNNH2)(OH2)](BF4) ([9]BF4): Yield 97 %,
185.4 mg. 1H NMR (400 MHz, D2O, 21 °C): δ = 1.03 (m, 2 CH2),
1.21 (m, CH2), 1.29 (m, CH), 1.39 (m, CH2), 1.78 (m, CH), 2.11
(s, C6(CH3)6), 2.42 (s, CH3), 7.26 (d, 3JH,H = 7 Hz, C6H4), 7.74 (d,
3JH,H = 7 Hz, C6H4). 13C NMR (200 MHz, D2O, 21 °C): δ = 15.1
(C6(CH3)6), 21.3 (p-(CH3)C6H4SO2), 24.1 (CH2), 24.1 (CH2), 33.3
(CH2), 34.1 (CH2), 57.2 (CH), 61.0 (CH), 92.0 (C6Me6), 127.0 (p-
(CH3)C6H4SO2), 128.0 (p-(CH3)C6H4SO2), 137.8 (p-(CH3)
C6H4SO2), 143.0 (p-(CH3)C6H4SO2). MS (ESI): m/z = 550 [M]+.
C25H39BF4N2O3RuS (635.53): calcd. C 47.25, H 6.19, N 4.41;
found N 47.41, H 6.31, N 4.32.
Single Crystal X-ray Structure Analyses: A yellow crystal of com-
pound [R,R-3][Cl]·2CHCl3, obtained from recrystallisation of [R,R-
3][Cl] with chloroform by slow evaporation, was mounted on a Stoe
Imaging Plate Diffractometer System (Stoe & Cie, 1995) equipped
with a one-circle φ goniometer and a graphite-monochromator.
Data collection was performed at –100 °C using Mo-Kα radiation
(λ = 0.71073 Å). 133 exposures (6 min per exposure) were obtained
at an image plate distance of 70 mm with 0  φ  198° and with
the crystal oscillating through 1.5° in φ. The resolution was Dmin–
Dmax 12.45–0.81 Å. This compound crystallised in a noncentrosym-
metric orthorhombic cell [P212121, Flack parameter x = 0.00(5)].
The molecular formula of this compound is
{[RuCl(C12H18)(C6H14N2)]Cl(CHCl3)2}. The structure was solved
by direct methods using the program SHELXS-97[25] and refined
by full-matrix least-squares on F2 with SHELXL-97.[26] The posi-
tions of the protons N2H3 and N2H4 were derived from difference
Fourier maps and refined with the N–H distance constrained to
the theoretical value, the remaining hydrogen atoms were included
in calculated positions and treated as riding atoms using SHELXL-
97 default parameters. All non-hydrogen atoms, were refined aniso-
tropically. A semi-empirical absorption correction was applied
using MULABS (PLATON03, Tmin. = 0.804, Tmax. = 0.839). Se-
lected crystallographic data for the complex are summarised in
Table 3.
A yellow crystal of compound [S,S-4][BF4]2·H2O, obtained by
recrystallisation of [S,S-4][BF4]2 from water, was mounted on a
Stoe Mark II-Imaging Plate Diffractometer System (Stoe & Cie,
2002) equipped with a graphite monochromator. Data collection
was performed at –100 °C using Mo-Kα radiation (λ = 0.71073 Å).
171 exposures (6 min per exposure) were obtained at an image plate
distance of 135 mm, 171 frames with φ = 0° and 0  ω  171°,
with the crystal oscillating through 1° in ω. The resolution was
Dmin. – Dmax. 17.78–0.72 Å. This compound crystallises in a non-
centrosymmetric space group with an orthorhombic cell (P212121).
The absolute structure could not be defined [Flack parameter =
0.16(12)]. The molecular formula of this compound is
{[Ru(C12H18)(C6H14N2)(H2O)](BF4)2.(H2O)}. As a result of the
high disorder found in the anions and solvent molecules, the
SQUEEZE instruction in PLATON03[27] was used to calculate the
remaining potential solvent accessible area in the unit cell; 602.1 Å3
was calculated containing about 173 electrons. Therefore, one BF4
(4×41 electrons) per asymmetric unit was included in all further
calculations. The structure was solved by direct methods using the
program SHELXS-97[25] and refined by full-matrix least-squares
on F2 with SHELXL-97.[26] The hydrogen atoms were included in
calculated positions and treated as riding atoms using SHELXL-
97 default parameters. All non-hydrogen atoms were refined aniso-
Table 3. Crystallographic data for the structure of [R,R-3]-
[Cl]·2CHCl3.
Chemical formula C20H34Cl8N2Ru
Formula mass 687.16
Crystal colour and shape yellow block
Crystal size 0.30×0.20×0.10
Crystal system orthorhombic
Space group P212121
a [Å] 9.04557(8)
b [Å] 15.5966(9)
c [Å] 20.1964(12)
α [°] 90
β [°] 90
γ [°] 90
V [Å3] 2849.4(3)
Z 4
Dcalcd. [g·cm–3] 1.602
µ (Mo-Kα) [mm–1] 1.313
Temperature [K] 173(2)
F(000) 1392
Scan range [°] 2 θ  25.75
Cell refinement parameters reflections 8000
Reflections measured 22511
Independent reflections 5556
Reflections observed [I  2σ(I)] 3385
Rint 0.1068
Final R indices [I  2σ(I)] 0.0369
R indices (all data) 0.0820
Goodness-of-fit 0.747
Residual density: max., min. ∆ρ [e·Å–3] 0.524, –1.200
The structure was refined on Fo2: wR2 = {Σ[w(Fo2 – Fc2)2]/
Σw(Fo2)2}1/2, where w–1 = [Σ(Fo2) + (aP)2 + bP] and P =
[max(Fo2,0) + 2Fc2]/3
Table 4. Crystallographic data for the structure of [S,S-4][BF4]2·
H2O.
Chemical formula C18H36B2F8N2O2Ru
Formula mass 587.18
Crystal colour and shape yellow block
Crystal size [mm] 0.25×0.18×0.10
Crystal system orthorhombic
Space group P212121
a [Å] 10.4410(8)
b [Å] 15.2988(16)
c [Å] 15.9586(13)
α [°] 90
β [°] 90
γ [°] 90
V [Å3] 2549.1(4)
Z 4
Dcalcd. [g cm–3] 1.530
µ (Mo-Kα) [mm–1] 0.690
Temperature [K] 173(2)
F(000) 1200
Scan range [°] 1.84  θ  25.18
Cell refinement parameters reflections 8869
Reflections measured 15808
Independent reflections 4528
Reflections observed [I  2σ(I)] 2748
Rint 0.1083
Final R indices [I  2σ(I)] 0.0743
R indices (all data) 0.1122
Goodness-of-fit 0.968
Residual density: max., min. ∆ρ [eÅ–3] 0.774, –1.471
The structure was refined on Fo2: wR2 = {Σ[w(Fo2 – Fc2)2]/
Σw(Fo2)2}1/2, where w–1 = [Σ(Fo2) + (aP)2 + bP] and P =
[max(Fo2,0) + 2Fc2]/3
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tropically. Selected crystallographic data for the complex are sum-
marised in Table 4.
CCDC-273653 (for [3]Cl·2CHCl3) and -273652 (for [4](BF4)2·H2O)
contain supplementary crystallographic data for this paper. These
data can be obtained free of charge via www.ccdc.cam.ac.uk/data_
request/cif, by emailing data_request@ccdc.cam.ac.uk, or by con-
tacting The Cambridge Crystallographic Data Centre, 12, Union
Road, Cambridge CB2 1EZ, UK; Fax: +44-1223-336033.
Transfer Hydrogenation Catalysis: The transfer hydrogenation reac-
tions of acetophenone (1 mmol), using 1–9 as their chloride (1–3
and 5–8) or sulfate (4 and 9) salts (10 µmol) with HCOONa
(5 mmol), were carried out in water (5 mL) in an inert atmosphere.
The reactions were quenched by cooling the mixtures to 0 °C. The
products were extracted with Et2O, filtered through silica and iden-
tified (and conversion and enantiomeric excesses were determined)
by HPLC on a Chiracel OB-H capillary column for acetophenone
and its Br and Me para-substituted derivatives or by gas
chromatography on a 6-tert-butyl-2,3-diethyl-β-cyclodextrin (30 %
in 5% phenyl polymer) capillary column for the CF3, NO2 and
MeO para-substituted substrates. The pH was monitored using a
pH meter (Mettler Toledo InLab® 413) and adjusted using HNO3
(for pH = 4 to 9) or NaOH (for pH = 10).
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